Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Intuitive Surgical Inc. Q3 2008 Earnings Conference Call Transcript
- Question-and-Answer Session[Operator Instructions]. Today's first question comes from Sean Levin. Sir, your line is open. Sean Levin - Lazard Capital Thank you. Congratulations on another strong quarter. Benjamin Gong - Vice President of Finance Thanks Sean. Sean Levin - Lazard Capital Sure. My first question has to do with...
- Earnings calls 2008-10-16
Additional Resources
- Colorectal Cancer: Basic Facts on Screening
- This paper provides information on screening tests used to cure colorectal cancer. Colorectal cancer is the 2nd leading cancer killer in the U.S. But if everyone age 50 or older had regular screening tests, at least one third of deaths from this disease could be avoided. People who have polyps...
- White papers 2002-03-01
- Colorectal Cancer Screening: For People With Medicare
- This paper summarizes and provides in-depth information on Colorectal cancer. Colorectal cancer is the 2nd leading cancer killer in the U.S. But if everyone age 50 or older had regular screening tests, at least one third of deaths from this disease could be avoided. Colorectal cancer occurs most often in...
- White papers 2003-04-01
- Colorectal Cancer: Let's Break the Silence
- This paper summarizes and provides information about Colorectal cancer. Colorectal cancer, or cancer of the colon or rectum, is the second-leading cause of cancer-related deaths in the United States, claiming over 56,000 lives this year. An estimated 129,400 men and women will be diagnosed with colorectal cancer this year alone....
- White papers 2001-05-18
- Colorectal Cancer: Facts on Screening
- This paper provides information on screening tests used in the cure of colorectal cancer. Colorectal cancer is the 2nd leading cancer killer in the U.S. But if everyone age 50 or older had regular screening tests, at least one third of deaths from this disease could be avoided. Colorectal cancer...
- White papers 2002-03-01
- Colorectal Cancer: Facts for People With Medicare
- This paper provides information on screening tests and Medicare program used in the cure of colorectal cancer. Colorectal cancer is the 2nd leading cancer killer in the U.S. But if everyone age 50 or older had regular screening tests, at least one third of deaths from this disease could be...
- White papers 2003-04-01
- Colorectal Cancer Screening: Saving Lives
- This paper elaborates and provides information on Screening used to cure colorectal cancer. Colorectal cancer is the 2nd leading cancer killer in the U.S. But if everyone age 50 or older had regular screening tests, at least one third of deaths from this disease could be avoided. Colorectal cancer occurs...
- White papers 2002-03-01
- The Case for Population-Based Screening for Colorectal Cancer
- Screening for colorectal cancer is commanding increasing attention. Other cancer screening programmes have been a part of public consciousness for some time, but, until recently, colorectal cancer screening has remained in the background. Fuelled by new research, market opportunities and increased recognition of individual risk, screening for colorectal cancer is...
- White papers 2002-01-01
- GAO: most private health plans cover colorectal screening
- EVEN IN STATES WITHOUT colorectal cancer screening coverage requirements, most private health plans provide coverage for colorectal screening tests. EVEN IN STATES WITHOUT colorectal cancer screening coverage requirements, most private health plans provide coverage for colorectal screening tests.
- Research articles 2004-08-09
- The Impact of Age on Post-Operative Outcomes of Colorectal Cancer Patients Undergoing Surgical Treatment
- The purpose of study was to evaluate the impact of age on outcomes in colorectal cancer surgery. Patients on hospital database treated for colorectal cancer during the period 1995 - 2002 were divided into two groups: Group 1 - patients of 75 years or older (n = 154), and Group...
- White papers 2005-12-02
- US DEPT OF HHS: National colorectal cancer action campaign announced by CDC, HCFA, NCI.
- M2 PRESSWIRE-3 March 1999-US DEPT OF HHS: National colorectal cancer action campaign announced by CDC, HCFA, NCI C1994-99 M2 COMMUNICATIONS LTD RDATE:020388 -- "Screen for Life" launched in response to new data revealing that too few Americans use colorectal cancer screening...
- Research articles 1999-03-03
- Millennium Initiates Phase II Clinical Trial With VELCADE (Bortezomib) for Injection in Patients With Colorectal Cancer
- In this article Millennium Pharmaceuticals, Inc. discusses the recent initiation of a phase II clinical trial of VELCADE in patients with colorectal cancer. The randomized, open-label study assesses the response rates of patients with refractory metastatic colorectal cancer to treatment with VELCADE alone or VELCADE plus CamptosarR irinotecan hydrochloride injection....
- White papers
- Development and Initial Testing of a Computer-Based Patient Decision Aid to Promote Colorectal Cancer Screening for Primary Care Practice
- Although colorectal cancer screening is recommended by major policy-making organizations, rates of screening remain low. The aim of this study was to develop a patient-directed, computer-based decision aid about colorectal cancer screening and investigate whether it could increase patient interest in screening. It used content from evidence-based literature reviews and...
- White papers 2005-11-28
- ImClone Systems receives European Patent Allowance For Colorectal Cancer Vaccine
- NEW YORK--HealthWire--Feb. 6, 1996--ImClone Systems Incorporated (Nasdaq: IMCL) announced today that the Company has received notice from the European Patent Office of an intent to grant a European patent for the Company's colorectal cancer vaccine, 105AD7. 105AD7 is a human monoclonal antibody which mimics an antigen known as...
- Research articles 1996-02-06
- ImClone Systems receives European Patent Allowance For Colorectal Cancer Vaccine
- NEW YORK--HealthWire--Feb. 6, 1995--ImClone Systems Incorporated (Nasdaq: IMCL) announced today that the Company has received notice from the European Patent Office of an intent to grant a European patent for the Company's colorectal cancer vaccine, 105AD7. 105AD7 is a human monoclonal antibody which mimics an antigen known as...
- Research articles 1996-02-06
- Statement of the American Cancer Society on the Eliminate Colorectal Cancer Act
- WASHINGTON, July 10 /U.S. Newswire/ -- The following is a statement of the American Cancer Society on the Eliminate Colorectal Cancer Act: WASHINGTON, July 10 /U.S. Newswire/ -- The following is a statement of the American Cancer Society on the Eliminate Colorectal Cancer Act:
- Research articles 2002-07-10
- HHS Urges Colorectal Cancer Screening To Save Lives
- WASHINGTON, March 13 /U.S. Newswire/ -- HHS Secretary Tommy G. Thompson today affirmed the value of colorectal cancer screening and encouraged Americans age 50 or older to get screened. WASHINGTON, March 13 /U.S. Newswire/ -- HHS Secretary Tommy G. Thompson today affirmed the value of colorectal cancer screening and encouraged...
- Research articles 2002-03-13
- NBC Today Show Co-Anchor Katie Couric and Dr. Sidney Winawer to Be Honored at Colorectal Cancer Network Event
- KENSINGTON, Md., May 8 /U.S. Newswire/ -- The Colorectal Cancer Network CCNetwork, a patient support and advocacy organization, today announced it will honor NBC TODAY show co-anchor Katie Couric and Dr. Sidney Winawer of Memorial Sloan-Kettering CancerKENSINGTON, Md., May 8 /U.S. Newswire/ -- The Colorectal Cancer Network CCNetwork, a patient...
- Research articles 2003-05-08
- Major League Baseball's Athletic Trainers Join Fight Against Colorectal Cancer at Spring Training
- WASHINGTON, March 21 /U.S. Newswire/ -- Throughout the month of March, the athletic trainers of Major League Baseball will help raise awareness of colorectal cancer at Spring Training games throughout Florida and Arizona. The athletic trainers, all membeWASHINGTON, March 21 /U.S. Newswire/ -- Throughout the month of March, the...
- Research articles 2002-03-21
- Antibody and medicine combine to fight colorectal cancer
- WASHINGTON AFP ? A monoclonal antibody, cetuximab, combined with irinotecan treatment is more effective against colorectal cancer than the antibody on its own, according to a study published in The New England Journal of Medicine. A research team headed by David Cunningham, of the Royal Marsden Hospital in London,...
- Research articles 2004-07-21
- << Previous
- page 1 of 1
- Next >>
